DNA tests for colon cancer aren't cost effective, study says

09/22/2010 | Reuters

Researchers said unless Medicare approves coverage of DNA testing for colon cancer or prices for the procedure drop considerably it will not be a cost-effective screening tool. Medicare already covers colonoscopy, flexible sigmoidoscopy, barium enema and fecal occult blood testing, all less expensive but effective colon cancer tests.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC